Branched multipeptide immunotherapy for glioblastoma using human leukocyte antigen-A*0201-restricted cytotoxic T-lymphocyte epitopes from ERBB2, BIRC5 and CD99

We investigated the use of cytotoxic T-lymphocyte (CTL) epitopes in peptide immunotherapy for glioblastoma. Three peptides (ERBB2, BIRC5 and CD99) were selected based on their peptide-T2 cell binding affinities and combined in a multipeptide cocktail or a branched multipeptide synthesized with mini-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Kim, Young-Hee, Tran, Thi-Anh-Thuy, Lee, Hyun-Ju, Jung, Sook-In, Lee, Je-Jung, Jang, Wool-Youl, Moon, Kyung-Sub, Kim, In-Young, Jung, Shin, Jung, Tae-Young
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5226601/
https://ncbi.nlm.nih.gov/pubmed/27409668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10495
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados